drugset / Trial / NCT07185035
An Exploratory Clinical Study on the Safety and Efficacy of Autologous NK Cells in the Treatment of Pulmonary Nodules
Phase 0
Recruiting
24 enrolled
The First Affiliated Hospital with Nanjing Medical University
Rui Therapeutics Co., Ltd · collab
NaSingle-groupOpen-labelTreatment
Summary
A single-center, open-label dose-escalation design to evaluate the safety and efficacy of KN5001 in patients with pulmonary nodules.
Timeline
- Start
- 2025-09-20
- Primary completion
- 2026-09-20
- Completion
- 2027-09-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KN5001 | Unknown | — | — |